As biotech companies face increased competition and expiring patents in the 1980s, they increasingly turn to bioprospecting to supplement synthetic product development. Drug companies scour Indigenous communities for traditional medicines to patent and develop for production. This is largely done without obtaining consent from or sharing profits with the holders of traditional healing knowledge.